Clinical Trial Update: A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma [Phase 4]

View source ↗

Summary

A Phase 4 trial compares the combination inhaled corticosteroid/long-acting beta-agonist Advair Diskus 250/50 mcg twice daily with Flovent Diskus 250 mcg twice …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ADVAIR DISKUS (fluticasone propionate and salmeterol)
• Flovent Diskus (fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2010-02-15